Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 287 of 6351
-
New catheter could improve stroke recovery
Disease control Not yet recruitingThe objective of this study is to evaluate the safety and effectiveness of the SOFIA Flow 88 Aspiration Catheter for treatment of acute ischemic stroke.
Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for Alzheimer's? phase 3 trial of brain-fueling compound begins
Disease control Not yet recruitingThe purpose of this study is to evaluate the effects of tricaprilin (20 g twice a day) on cognition, global function, activities of daily living, resource utilisation, safety, and tolerability, in participants with mild to moderate AD dementia. This is a randomised, double-blind…
Phase 3 • Sponsor: Cerecin • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Virtual reality and glowing dye could make lung cancer surgery safer
Disease control Not yet recruitingWith the advent of CT screening for lung cancer, an increasing number of NSCLCs are being detected at very early stages, and the demand for pulmonary segmentectomy is rising rapidly. As such, there is a need to develop new surgical techniques to facilitate minimally invasive pulm…
Phase 1/2 • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Low-Dose erlotinib aims to stop liver cancer before it starts
Prevention Not yet recruitingThis phase II randomized placebo-controlled trial studies low-dose erlotinib treatment to assess its efficacy and safety to prevent development of hepatocellular carcinoma in patients with advanced liver fibrosis or cirrhosis.
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Balloon in the womb: new hope for babies with underdeveloped lungs?
Disease control Recruiting nowThe purpose of this research is to gather information on the safety and effectiveness of a procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO) at Mayo Clinic. The intent of the FETO procedure is to improve development of the lungs in fetuses diagnosed with severe co…
Sponsor: Mauro H. Schenone • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill aims to keep leukemia away after transplant
Disease control Not yet recruitingRevumenib is a first in class oral menin inhibitor that targets a central oncogenic dependency shared across KMT2Ar, NPM1m, and NUP98r AML. In addition to suppressing leukemogenic transcriptional programs and promoting leukemic differentiation, menin inhibition has been shown to …
Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New shot aims to reduce bulging eyes from thyroid disease
Disease control Not yet recruitingThe primary objective of this study is to evaluate the efficacy of MHB018A injection compared with placebo in participants with active moderate-to-severe TED.
Phase 3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Major trial pits drugs vs. surgery vs. stents for failing hearts
Disease control PausedThe ISCHEMIA-HF trial will randomize participants with multivessel coronary artery disease (CAD) with ejection fraction (EF) ≤40% in a 1:2:2 fashion to guideline-directed medical therapy (GDMT):coronary artery bypass grafting (CABG):percutaneous coronary intervention (PCI).
Phase 3 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Donor 'Memory' immune cells take on childhood cancer
Disease control Recruiting nowThe goal of this study is to demonstrate that cytokine-induced memory-like natural killer cells (CIML-NK cells) can be generated from donor cells and infused safely into patients with relapsed or refractory neuroblastoma during dinutuximab-based therapy.
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New cocktail of drugs takes on Hard-to-Treat bladder cancer
Disease control Not yet recruitingThis phase Ib/II trial tests the safety, side effects, and best dose of quemliclustat in combination with enfortumab vedotin and pembrolizumab, and to see how well the combination works for the treatment of bladder, renal pelvis, or ureter urothelial cancer that cannot be removed…
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Zapping the heart back to rhythm: a new device uses pulsed fields to treat atrial fibrillation
Disease control Not yet recruitingThis study will evaluate the long-term safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal atrial fibrillation.
Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a menin inhibitor tame myelofibrosis when standard drugs fall short?
Disease control Not yet recruitingThis is a Phase Ib/II 2 study investigating the safety and efficacy of revumenib in two cohorts of participants with myelofibrosis. COHORT-1 will investigate the safety of revumenib as monotherapy in participants with myelofibrosis previously treated with a JAK inhibitor. Followi…
Phase 1/2 • Sponsor: John Mascarenhas • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
App-based therapy aims to break teen vaping addiction
Disease control Not yet recruitingThis clinical trial compares a novel smartphone application (app) called QuitQuest to the National Cancer Institute's (NCI's) SmokefreeTeenQuitVaping (SFTQV) app in helping teens stop vaping. Despite recent declines, data shows that 8.5% of middle school (grades 6-8) and 18.1% of…
Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can mindfulness together ease the burden of advanced cancer?
Symptom relief Recruiting nowThe overall objective of this study is to learn whether a newly developed couple-based mindfulness program (Mindful PaCT) is practical to complete (feasible), helpful and well-received (acceptable), and relevant for patients with metastatic colorectal cancer (mCRC) and their part…
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Wearable vest aims to boost milk flow and prevent blocked ducts
Symptom relief Not yet recruitingAI-Based Oxytocin-Stimulated Smart Lactation Support Vest: Development of a Thermo-Massage and Vibration Wearable Vest Design to Support Milk Flow and Prevent Milk Duct Obstruction During Lactation
Sponsor: Selcuk University • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Zapping a deep brain region might boost social understanding in autism
Symptom relief Not yet recruitingDespite decades of research, no definitive, effective biological treatments exist for core symptoms of Autism Spectrum Disorder (ASD). Emerging evidence suggests that conventional Transcranial Magnetic Stimulation (TMS) targeting the dorsolateral prefrontal cortex or posterior su…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Could a workout help your brain take out the trash?
Knowledge-focused Not yet recruitingThis is a prospective, interventional, non-blinded, single center research project that will recruit cognitively unimpaired subjects in the 25-55 year old and 55-75 year old range. This study will use acute aerobic exercise as a natural intervention model to increase cardiac acti…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can a Stop-Smoking drug curb marijuana use?
Disease control Not yet recruitingMarijuana is the most commonly used illicit drug, and there is a high demand for effective treatments for cannabis use disorder, yet few specific pharmacological treatments have been developed. This study will evaluate the efficacy and safety of varenicline for reducing marijuana…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Smartwatch may end the dreaded 24-hour blood pressure cuff
Diagnosis Not yet recruitingBackground: Ambulatory Blood Pressure Monitoring (ABPM) is the gold standard for diagnosing high blood pressure (hypertension) because it tracks blood pressure continuously across day and night. However, standard ABPM requires a cuff that inflates every 15 to 30 minutes during t…
Sponsor: Sunway University • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Can a traditional herbal mix save limbs from diabetic ulcers?
Disease control Not yet recruitingThis study evaluates the clinical efficacy and safety of a Modified Simiao Yongan Decoction when used alongside standard endovascular therapy and wound care for the treatment of diabetic foot ulcers. The trial focuses on patients presenting with the damp-heat toxins accumulation …
Sponsor: Chengdu University of Traditional Chinese Medicine • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC